Composition for treating schizophrenia
CA 1048932 A · Owner: Nelson Research And Development Company · Inventors: Fuxe, Kjell
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Known neuroleptic drugs used to treat schizophrenia include phenothiazines such as chloropromaxine; butyrophenones such as haloperiodal and others such as pimocide and clozapine. Underirable side effects of neuroleptic drugs include sedation and tardive dyskinesias. The latter side effect is particularly important because it results in involuntary muscle movements especially of the face and mouth which become reversible. The onset of this side effect is directly related to the amounts of and length of time which a neuroleptic drug is used in treatment. There has now been discovered a composition for treating schizophrenia and a method and composition for potentiating the beneficial effects …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted February 20, 1979. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 20, 1996.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.